Cira Discovery Sciences

Cira Discovery Sciences is a biotechnology company focused on the discovery and development of novel small molecule therapeutics using a proprietary computational platform. The company's core technology, known as Cira, is designed to identify potent and selective ligands for challenging drug targets, with a particular emphasis on G protein-coupled receptors (GPCRs). By combining computational modeling with experimental validation, Cira Discovery Sciences aims to significantly reduce the time and cost associated with early-stage drug discovery. The company targets a range of therapeutic areas, including oncology, metabolic diseases, and neurology, to address significant unmet medical needs. Headquartered in Pennsylvania, the firm operates as a private entity focused on high-throughput virtual screening and lead optimization.